Single-Cell RNA Sequencing Reveals Alterations in Patient Immune Cells with Pulmonary Long COVID-19 Complications.

CD8+ NKT cells ScType long COVID-19 neutrophils scRNA-seq

Journal

Current issues in molecular biology
ISSN: 1467-3045
Titre abrégé: Curr Issues Mol Biol
Pays: Switzerland
ID NLM: 100931761

Informations de publication

Date de publication:
02 Jan 2024
Historique:
received: 16 11 2023
revised: 19 12 2023
accepted: 20 12 2023
medline: 22 1 2024
pubmed: 22 1 2024
entrez: 22 1 2024
Statut: epublish

Résumé

Since the emergence of the COVID-19 pandemic, the effects of SARS-CoV-2 have been extensively researched. While much is already known about the acute phase of the infection, increasing attention has turned to the prolonged symptoms experienced by a subset of individuals, commonly referred to as long COVID-19 patients. This study aims to delve deeper into the immune landscape of patients with prolonged symptoms by implementing single-cell mRNA analysis. A 71-year-old COVID-19 patient presenting with persistent viral pneumonia was recruited, and peripheral blood samples were taken at 3 and 2 years post-acute infection onset. Patients and control peripheral blood mononuclear cells (PBMCs) were isolated and single-cell sequenced. Immune cell population identification was carried out using the ScType script. Three months post-COVID-19 patients' PBMCs contained a significantly larger immature neutrophil population compared to 2-year and control samples. However, the neutrophil balance shifted towards a more mature profile after 18 months. In addition, a notable increase in the CD8+ NKT-like cells could be observed in the 3-month patient sample as compared to the later one and control. The subsequent change in these cell populations over time may be an indicator of an ongoing failure to clear the SARS-CoV-2 infection and, thus, lead to chronic COVID-19 complications.

Identifiants

pubmed: 38248331
pii: cimb46010029
doi: 10.3390/cimb46010029
doi:

Types de publication

Journal Article

Langues

eng

Pagination

461-468

Subventions

Organisme : European Regional Development Fund (ERDF)
ID : 1.1.1.1/21/A/029

Auteurs

Kristīne Vaivode (K)

Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.

Rihards Saksis (R)

Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.

Helēna Daiga Litvina (HD)

Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.

Helvijs Niedra (H)

Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.

Marta Līva Spriņģe (ML)

Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.

Una Krūmiņa (U)

Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.

Jānis Kloviņš (J)

Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.

Vita Rovite (V)

Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.

Classifications MeSH